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Flavonoids as Enhancers of X-Ray-induced Cell Damage in
Hepatoma Cells
Johannes van Rijn’ and Jaap van den Berg
Department of Radiotherapy, Academic Hospital Vrije Universiteit,
Amsterdam, the Netherlands
ABSTRACT
The nuclear enzyme topoisomerase II, which is involved
in replication, transcription, and probably repair of DNA,
can be inhibited by a number of flavonoids. In conjunction
with X-rays, three of these compounds were tested as to their
effects on Reuber H35 hepatoma cells. In this combination,
the isoflavone genistein, the flavone apigenin, and the flavo-
nol quercetin caused an enhancement of radiation-induced
cell death. This enhanced cytotoxicity was only observed
when the flavonoids were applied following an irradiation
treatment and is attributed to decreased repair of DNA
radiation damage with a concomitant reduction of the rate
of cell repopulation. Fractionated irradiations, given as five
sequences of 3 Gy each over a period of 5 days, reduced the
surviving cell population only by a factor of 20, whereas the
continuous presence of genistein during radiation sequences
resulted in a reduction of at least a factor of 10,000. Thus,
these flavonoids not only seem to act as radiation enhancers
but also exhibit potential antitumor activities.
INTRODUCTION
Topoisomerase II is a nuclear enzyme that transiently
forms and then religates breakages in both DNA strands during
replication, transcription, and other DNA-related processes (I).
Some recent studies suggest that the topoisomerases are also
involved in repair of radiation-induced DNA damage. Thus, the
topoisomerase II inhibitor etoposide was shown to cause radi-
ation sensitization in V79 lung fibroblasts and human melanoma
cells (2, 3). Several bioflavonoids were also shown to act as
inhibitors of topoisomerase II (4, 5). Of the ones chosen for the
present study, the isoflavone genistein exhibits a variety of
effects on cells, including inhibition of proliferation and induc-
tion of differentiation in tumor cells (6-9). It also increases
radiation-induced delays of the G2 subdivision in mouse zygotes
(10). The structurally related flavone apigenin causes arrest in
the G2-M growth phase and leads to morphological differenti-
ation in rat neuronal cells ( 1 1 ), whereas the flavonol quercetin
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exhibits antiproliferative properties in various cancer cells in
vitro ( 12). The latter compound recently underwent a Phase I
clinical trial (13). To our knowledge, the present study is the
first report that examines the usefulness of flavonoids as mod-
ifying and enhancing agents of radiation-induced loss of cellular
clonogenic capacities. The effects of the mentioned flavonoids
were investigated on rat hepatoma cells treated with single
X-ray doses, whereas the effects of genistein were also studied
in combination with fractionated irradiations.
MATERIALS AND METHODS
Reuben H35 rat hepatoma cells were cultured in 25 cm2
TC2 flasks (NALGE NUNC Industries) in L I 5 medium supple-
mented with 10% fetal bovine serum (Life Technologies, Inc.).
The cells were processed for the clonal assay at the end of the
experimental procedures. After trypsmnization and serial dilu-
tion, 500-20,000 cells were seeded in duplicate in TC flasks.
After 10 days, the cell colonies were fixed with ethanol and
stained with Giemsa solution. Colonies containing 50 on more
cells were scored. The cloning efficiency of untreated H35 cells
was at least 90%. Cultures for experiments contained approxi-
mately 500,000 cells in the logarithmic growth phase. Irradia-
tion occurred with an orthoV (175 kV) X-ray beam at a dose rate
of 50 cGy/min (Philips, Eindhoven, the Netherlands). Fla-
vonoids (Sigma Chemical Co.) were dissolved in DMSO (10 mg
in 0. 1 ml DMSO) and directly diluted in culture medium to give
a stock concentration of 240 p.M. Control cultures were given
the same amount of solvent, which did not affect clonogenicity.
RESULTS
Effects of the Flavonoids on Single-Dose Irradiated
Cells. During the explonative phase of this study, exponen-
tially growing cells were treated with various concentrations of
genistein for various lengths of time either before, during, or
following irradiation. Preincubation of the hepatoma cells with
genistein for periods of up to 24 h did not affect the survival of
irradiated cells (results not shown). However, treatment with
genistein after irradiation caused an additional reduction in cell
survival. To assess the effects of genistein, the compound was
added 30 mm before irradiation, and incubation was continued
until 24 h, when the cells were plated to determine clonal
survival. Irradiated cells were also plated immediately because
delayed plating usually resulted in an increase of the surviving
cell population due to cell division and repair of potential lethal
damage.
Fig. I shows the results of irradiated cultures incubated
with genistein for a total of 24 h. The enhancement of radiation
2 The abbreviations used are: TC, tissue culture: PTK, protein tyrosine
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Fig. 2 Cytotoxicity of the flavonoids. Cells were exposed to various
concentrations of genistein (A), apigenin (#{149}),or quercetin (#{149})for 24 h.
Dose(, M, 24h)
30 60
Genistein, M
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Fig. 1 Effect of genistein concentration on growth and survival of
irradiated cells. Genistein (0-90 p.M) was added 30 mm before irradi-
ation with 4 Gy X-rays, and the incubation was continued for 23.5 h
followed by the clonal assay. a, cell survival; b. number of cells per TC
flask; 0. irradiated cells: U, nonirradiated cells: , number of cells
at the time of irradiation.
damage was evident from a concentration of 30 p.M genistein
(Fig. lc,). Furthermore, genistein inhibited cell proliferation in a
dose-dependent manner that appears to be independent of the
radiation-induced growth delay (Fig. lh).
To test the efficiency of the X-nays, graded doses up to 8
Gy were applied to cells that were treated with 60, 90, or 120 p.M
genistein. In addition, we investigated the related flavonoids
apigenin (60 p.M) and quencetin (90 p.M) likewise from 30 mm
before irradiation until 23.5 h following this treatment. The
concentrations of the latter compounds were the optimum values
providing the lowest cytotoxicity in coincidence with the high-
est degree of radiation enhancement. Genistein cytotoxicity
(1C5() --75 p.M) was intermediate to that of apigenin (IC50 =
-50 p.M) and quencetin (IC50 - 100 p.ri; Fig. 2). The three
genistein concentrations caused a similar dose-dependent en-
hancement of radiation-induced cell death after correction for
genistein toxicity (Fig. 3). The optimum dose of genistein there-
fore appears to be between 40 and 60 p.M. The radiation en-
hancement by apigenin and quercetin was smaller than for
genistein. The first two flavonoids showed a dose reduction
factor at surviving fraction 0. 1 of 1 .5 as opposed to 2.0 for
genistemn. Drug treatment, either alone on in combination with a
low dose of X-rays, almost completely prevented cell population
growth (Fig. 3, h, d, andf).
The enhancement effect of genistein in irradiated H35 cells
is in contrast with the radiation protection by genistein in human
B-lymphocyte precursors (14), which is attributed to its inhibi-
tion of PTKs. Therefore, in our protocol, we also tested the PTK
inhibitor tyrphostin 5 1 and the tyrosine phosphatase inhibitor
vanadate, which has the opposite effect of genistein in B-
lymphocyte precursors. The selected concentrations of the two
compounds inhibited the proliferation of H35 cells as effectively
as genistein, alone and in combination with X-rays (Table 1).
Tyrphostin 5 1 seemed to prevent the delayed plating recovery
without causing any radiation sensitization. Vanadate caused an
additional enhancement in combination with X-rays, which,
however, does not agree with its putative antagonistic action to
genistein.
Effects of Genistein on Cells Treated with Fractionated
Doses of X-Rays. Genistein used at 60 p.M did not lead to
notable increases in cytotoxicity when used for longer periods
than 24 h. To study the effects of genistein in combination with
fractionated irradiations, cells were incubated continuously with
60 or 90 p.M genistein and subjected to five doses of 3 Gy of
X-rays given at 24-h intervals. The surviving cell fraction was
assessed prior to and following every irradiation to determine
recoveries in the preceding interval and the reduction of cell
survival per radiation dose. The cytotoxicity of 60 p.M genistein
did not change significantly after the first 24-h period; the
cloning efficiency remained at about 50% (Fig. 4a). At 90 p.M.
genistein became increasingly cytotoxic, leading to less than 3%
survival after 96 h. Sixty p.M genistein caused partial growth
inhibition when compared with untreated cells, whereas 90 p.M
genistein led to complete cellular stasis (Fig. 4b).
Fractionated irradiation caused a progressive reduction of
the cell proliferation (Fig. 4c), which turned into a regression in
combination with genistein. Genistein also strongly reduced the
number of surviving cells in the irradiated cultures (Fig. 44
The initial cell number of approximately 500,000 cells per
culture was reduced by only a factor of 20 following the X-ray
doses, whereas in the presence of 60 or 90 p.M genistein, the
number of cells surviving irradiation was reduced by at least a
factor of 10,000. With respect to the fraction of surviving cells
(Fig. 4e), the (equivalent) dose reduction factor at surviving
fraction 0. 1 for 60 p.M genistein is 2.3, which is comparable with
the 2.0 for single-dose irradiation (Fig. 3).
X-rays caused a dose-dependent mitotic delay in cells, but
the effect of 3 Gy was smaller than that of 24 h of incubation
with 60 p.M genistein (Fig. 4, b and c). This is demonstrated in
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Fig. 3 Comparison of the effects of genistein, quencetin, and apigenin on irradiated cells. Flavonoids were added 30 mm prior to X-rays, and the
incubation was continued for 23.5 h. a and b: A,60 p.M genistein; A, 90 p.M genistein; I, 120 p.M genistein. c and d: LI, 90 psi quercetin. e and 1.
Ls, 60 p.M apigenin. a, c, and e, fraction of surviving cells; curves are normalized for drug toxicity (marked on the ordinate). Control-irradiated cells
were plated both immediately (0) and after 23.5 h (#{149}).b, d. andf number of cells per TC flask: , number of cells at the time of irradiation.
Table 1 Effect of tyrphostine and vanadate on proliferation and
survival of irradiated cells
The PTK inhibitor tyrphostin 51 (100 pM) and the tyrosine phos-
phatase inhibitor vanadate (100 p.M) were compared with genistein (60
p.M) for their effect on irradiated cells. Cells were exposed to the various
compounds from 30 mm prior to irradiation with 5 Gy X-rays until
23.5 h after irradiation. Irradiated cells without drugs were plated with
or without 24 h delay. None of the compounds caused more than 20%
reduction of the cloning efficiency in 24 h. Survival data were corrected
for drug toxicity.
Surviving
fraction
0 h 24 h
Proliferati
(0-24
No X-rays
on factor
h)
5 Gy
Control 1.0 1.0 3.5
5 Gy 0.08 0.12 1.6
Tyrphostin 51 0.08 1.7 1.0
Vanadate 0.05 1.6 0.9
Genistein 0.02 2.2 1.1
Table 2, which includes the results of a duplicate experiment.
Assuming that cell loss was negligible during the first interval of
fractionated irradiation, the increases in cell number reflect the
proliferation rates of the cultures. On the average, untreated
cultures increased their cell number by a factor of 3.4 during the
24-h interval. This factor was reduced to 2.65 after irradiation
with 3 Gy when all cells were included on to 3.1 when only the
surviving cells were considered. This apparent preferential re-
covery of surviving cells after irradiation was not observed in
the presence of genistein (growth factor, 1.3).
DISCUSSION
Postirradiation applications of the flavonoids genistein.
apigenin, or quercetin to hepatoma cells enhanced cell death.
The reduction of cell survival appears to be due to multiple
effects exerted by these compounds.
Genistein inhibits both platelet-derived growth factor- and
epidermal growth factor-induced mitogenesis and initiation of
DNA synthesis in quiescent rat liver cells and in mouse fibro-
blasts (15). These effects were thought to be related to inhibition
of PTKs ( I 6), although the kinetics of inhibition of genistein and
some other flavonoids on these PTKs do not closely correlate
with their inhibition of cell proliferation (17). In a study with
human B lymphocyte precursors, genistein-treated cells express
resistance to ionizing radiation with respect to apoptosis and
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Fig. 4 Effect of genistein on cells treated with
fractionated irradiation. Cell cultures were given
five fractions of 3 Gy X-rays at 24-h intervals in
the continuous presence of genistein, which was
renewed daily. a, effect of 60 (Li) or 90 (Lii) p.M
genistein on cell survival. b, proliferation of
untreated cells (Y) and the effect of 60 (A) or 90
(El) p.M genistein. C., proliferation of irradiated
cells (0) and the effect of 60 (A) or 90 () p.M
genistein. d, effect of fractionated irradiation
and genistein on the surviving cell population. e,
effect of 60 p.M genistein on the surviving frac-
tion of irradiated cells. d and e, after each irra-
diation, cultures of cells were put in the clonal
assay (, 0, and A) and again after 24 h prior
to the next radiation dose (U, #{149},and A). Cells
were irradiated alone (0 and S) or in the pres-
ence of 60 (A, and A) or 90 (fl and #{149})p.M
genistein. Data are corrected for drug toxicity
according to a. In e, curves are given only for
the delayed plating (A and #{149})using exponential
regression.
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Table 2 Effect of X-rays and genistein on cell proliferation
Cell proliferation is shown during the 24-h period following 3 Gy
X-rays in the presence or absence of 60 p.M genistein. Data are drawn
from Fig. 4 and from a similar fractionation experiment.
Proliferation f actor (0-24h)
Control Genistein
Control cells 3.4 (3.0-3.8) 1 .95 (1.6-2.3)
Irradiated cells 2.65 (2.5-2.8) 1.8 (1.7-1.9)
Surviving irradiated cells 3.1 (3.2-3.0) 1.3 (1.5-1.1)
proliferation inhibition, whereas vanadate, a tyrosine phospha-
tase inhibitor, has the opposite effect (14). In contrast with this
earlier study (14), genistein enhanced the radiation response in
H35 cells. Furthermore, treatment with the PTK inhibitor tyr-
phostin 5 1 led to inhibition of cell growth but did not affect any
radiation sensitization. These results suggest that PTK does not
play a role in the radiation-induced cell death in H35 cells. Most
likely, the responses to ionizing radiation are different for B-
lymphocyte precursors and the hepatoma cells. Irradiated
lymphoid cells undergo interphase death, which is expressed as
apoptosis, whereas radiation-induced cell death in H35 cells
appears to be mainly of the mitotic type. Genistein was also
shown to inhibit Taxol-induced apoptosis in human leukemic
cells and in some other studies (18).
Genistein can block the cell cycle in the G,-M phase,
which is possibly related to inhibition oftopoisomerase II (8, 10,
19). When irradiated cells are treated with genistein, a higher
frequency of DNA-protein cross links is found than after irra-
diation alone (4). The topoisomerase II inhibitor etoposide was
shown to cause radiation sensitization in V79 cells (2) and in
human melanoma cells (3). These results suggest an involve-
ment of topoisomerases in the repair of sublethal or potentially
lethal damage as caused by irradiation.
We have shown that in hepatoma cells, three different
flavonoids caused an enhancement of radiation toxicity and that
genistein in conjunction with a regime of fractionated radiation
did not allow recovery of the surviving cell population during
the intervals. It is therefore suggested that genistein and the
other flavonoids prevent repopulation, as well as repair of
radiation damage, possibly by inhibition of topoisomerase II
activity.
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